0000000000660474

AUTHOR

Sen Yang

showing 2 related works from this author

Bioconversion of Gibberellin Fermentation Residue into Feed Supplement and Organic Fertilizer Employing Housefly (Musca domestica L.) Assisted by Cor…

2014

The accumulation of a considerable quantity of gibberellin fermentation residue (GFR) during gibberellic acid A3 (GA3) production not only results in the waste of many resources, but also poses a potential hazard to the environment, indicating that the safe treatment of GFR has become an urgent issue for GA3 industry. The key to recycle GFR is converting it into an available resource and removing the GA3 residue. To this end, we established a co-bioconversion process in this study using house fly larvae (HFL) and microbes (Corynebacterium variabile) to convert GFR into insect biomass and organic fertilizer. About 85.5% GA3 in the GFR was removed under the following optimized solid-state fer…

Crop residueBioconversionlcsh:MedicineEnvironmental pollutionBiologyCorynebacteriumWaste ManagementHousefliesAnimalsDry matterOrganic matterFood scienceBiomasslcsh:ScienceFertilizerschemistry.chemical_classificationMultidisciplinarylcsh:Rfood and beveragesStrawAnimal FeedGibberellinschemistryAgronomyFermentationFermentationlcsh:QOrganic fertilizerResearch ArticlePloS one
researchProduct

Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignif…

2017

Chronic non-specific respiratory symptoms are difficult to manage. This trial aimed to evaluate the association between baseline fractional exhaled nitric oxide (FeNO) and the response to inhaled corticosteroids in patients with non-specific respiratory symptoms.In this double-blind randomised placebo-controlled trial, we enrolled undiagnosed patients, aged 18-80 years, with cough, wheeze, or dyspnoea and less than 20% bronchodilator reversibility across 26 primary care centres and hospitals in the UK and Singapore. Patients were assessed for 2 weeks before being randomly assigned (1:1) to 4 weeks of treatment with extrafine inhaled corticosteroids (QVAR 80 μg, two puffs twice per day, equi…

Pulmonary and Respiratory MedicineAdultMalePediatricsmedicine.medical_specialtyAdolescentmedicine.drug_classPlaceboNitric Oxidelaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawBronchodilatorWheezeInternal medicineAdministration InhalationmedicineHumans030212 general & internal medicineAnti-Asthmatic AgentsRespiratory systemAdverse effectAgedAged 80 and overInhalationbusiness.industryBeclomethasoneMiddle Agedrespiratory systemRespiration Disordersrespiratory tract diseasesTreatment Outcome030228 respiratory systemExhalationExhaled nitric oxideFemaleHuman medicinemedicine.symptombusiness
researchProduct